JNJ vs HCA
By Alex · Tickerpine
Johnson & Johnson vs HCA Healthcare, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | HCA |
|---|---|---|
| Price | $254.66 | $391.68 |
| Market cap | $613.02B | $86.89B |
| P/E ratio | 29.5 | 13.5 |
| ROE | 26.42% | — |
| Profit margin | 21.83% | 8.89% |
| Revenue growth | 9.90% | 4.30% |
| Dividend yield | 2.10% | 0.80% |
| Beta | 0.26 | 1.13 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs HCA in plain English
- JNJ is the bigger company — about 7.1× the market cap of HCA.
- HCA is cheaper on earnings (P/E 13.5 vs 29.5).
- JNJ is growing revenue faster (10% vs 4%).
- JNJ has the higher dividend yield (2.10% vs 0.80%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
HCA return calculator
See what $1,000 in HCA Healthcare, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.